Respiratory viral infections today, heart failure tomorrow: implications for prevention
The intersection between infectious diseases and cardiovascular outcomes has never been more pressing than in the post-COVID-19 pandemic era.Respiratory viral infections (RVIs)including influenza, SARS-CoV-2, and respiratory syncytial virus (RSV)-are increasingly recognized for their acute respiratory manifestations potentially leading to acute cardiovascular (CV) decompensations and systemic, particularly CV, sequelae.In their recent contribution to the European Journal of Preventive Cardiology, Wee et al. present compelling data quantifying the
Authors
- François Roubille (ORCID: https://orcid.org/0000-0002-5288-9687)
- Paul Loubet (ORCID: https://orcid.org/0000-0002-1218-9432)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Physiologie et Médecine Expérimentale du Coeur et des Muscles (FR)
- Bacterial Virulence and Chronic Infections
- Université de Nîmes (FR)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1093/eurjpc/zwaf731
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00